Dexamethasone preservation of motor function in phospholipase A2-induced caudate lesions.
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001519:Behavior / Q000187:drug effects*; D002421:Caudate Nucleus / Q000187:drug effects* / Q000378:metabolism; D003907:Dexamethasone / Q000494:pharmacology*; D006801:Humans; D008244:Lysophosphatidylcholines / Q000378:metabolism; D008297:Male; D009043:Motor Activity / Q000187:drug effects*; D010740:Phospholipases / Q000633:toxicity*; D010741:Phospholipases A / Q000037:antagonists & inhibitors / Q000633:toxicity*; D054467:Phospholipases A2; D010743:Phospholipids / Q000378:metabolism; D051381:Rats; D013239:Stereotyped Behavior / Q000187:drug effects*
D008244:Lysophosphatidylcholines; D010743:Phospholipids; D003907:Dexamethasone; D010740:Phospholipases; D010741:Phospholipases A; D054467:Phospholipases A2; D001058:Apomorphine